Literature DB >> 26416847

Generation of Hypertension-Associated STK39 Polymorphism Knockin Cell Lines With the Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 System.

Shintaro Mandai1, Takayasu Mori1, Eisei Sohara1, Tatemitsu Rai1, Shinichi Uchida2.   

Abstract

Previous genome-wide association studies identified serine threonine kinase 39 (STK39), encoding STE20/SPS1-related proline/alanine-rich kinase, as one of a limited number of hypertension susceptibility genes. A recent meta-analysis confirmed the association of STK39 intronic polymorphism rs3754777 with essential hypertension, among previously reported hypertension-associated STK39 polymorphisms. However, the biochemical function of this polymorphism in the mechanism responsible for hypertension is yet to be clarified. We generated rs3754777G>A knockin human cell lines with clustered regularly interspaced short palindromic repeats-mediated genome engineering. Homozygous (A/A) and heterozygous (G/A) knockin human embryonic kidney cell lines were generated using a double nickase, single-guide RNAs targeting STK39 intron 5 around single-nucleotide polymorphism, and a 100-bp donor single-stranded DNA oligonucleotide. Reverse transcription polymerase chain reaction with sequencing analyses revealed the identical STK39 transcripts among the wild-type and both knockin cell lines. Quantitative reverse transcription polymerase chain reaction showed increased STK39 mRNA expression, and immunoblot analysis revealed increases in total and phosphorylated STE20/SPS1-related proline/alanine-rich kinase with increased phosphorylated Na-K-Cl cotransporter isoform 1 in both knockin cell lines. The largest increases in these molecules were observed in the homozygous cell line. These findings indicated that this intronic polymorphism increases STK39 transcription, leading to activation of the STE20/SPS1-related proline/alanine-rich kinase-solute carrier family 12A signaling cascade. Increased interactions between STE20/SPS1-related proline/alanine-rich kinase and the target cation-chloride cotransporters may be responsible for hypertension susceptibility in individuals with this polymorphism.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  SLC12A transporters; SPAK protein; clustered regularly interspaced short palindromic repeats; hypertension; single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26416847     DOI: 10.1161/HYPERTENSIONAHA.115.05872

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  WNK Kinases in Development and Disease.

Authors:  Aylin R Rodan; Andreas Jenny
Journal:  Curr Top Dev Biol       Date:  2016-09-28       Impact factor: 4.897

2.  The CUL3/KLHL3-WNK-SPAK/OSR1 pathway as a target for antihypertensive therapy.

Authors:  Mohammed Z Ferdaus; James A McCormick
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-13

3.  Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension.

Authors:  Tianlun Gu; Shuqi Mao; Rui Fan; Fade Zhong; Fubao Zhu; Lingmei Hao; Lina Zhang; Fengying Yin
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

4.  Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy.

Authors:  Shintaro Mandai; Susumu Furukawa; Manami Kodaka; Yutaka Hata; Takayasu Mori; Naohiro Nomura; Fumiaki Ando; Yutaro Mori; Daiei Takahashi; Yuki Yoshizaki; Yuri Kasagi; Yohei Arai; Emi Sasaki; Sayaka Yoshida; Yasuro Furuichi; Nobuharu L Fujii; Eisei Sohara; Tatemitsu Rai; Shinichi Uchida
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

5.  Dietary salt with nitric oxide deficiency induces nocturnal polyuria in mice via hyperactivation of intrarenal angiotensin II-SPAK-NCC pathway.

Authors:  Y Sekii; H Kiuchi; K Takezawa; T Imanaka; S Kuribayashi; K Okada; Y Inagaki; N Ueda; S Fukuhara; R Imamura; H Negoro; N Nonomura
Journal:  Commun Biol       Date:  2022-02-28

Review 6.  Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension.

Authors:  Nur Farah Meor Azlan; Maarten P Koeners; Jinwei Zhang
Journal:  Acta Pharm Sin B       Date:  2020-09-22       Impact factor: 11.413

7.  WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4.

Authors:  Shintaro Mandai; Takayasu Mori; Naohiro Nomura; Taisuke Furusho; Yohei Arai; Hiroaki Kikuchi; Emi Sasaki; Eisei Sohara; Tatemitsu Rai; Shinichi Uchida
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.